Stock screenerAll disclosures →
EDGAR →
PTGX
Conviction 100HealthcareScan · Mon, Aug 10, 2026PTGX$149.94+2.79%
ResistanceSupportVol 14Insider sell2
Vol MA14 581.66K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price149.94
Change+2.79%
Gap+2.32%
Rel volume2.69×
Avg volume600.44K
Avg $ vol83.05M
SMA 20137.37
SMA 50124.41
SMA 20099.25
Price vs 50+20.53%
Price vs 200+51.08%
MA stackbullish
50/200 cross—
Supertrendup · 132.05
RSI (14)68
MACD hist0.52
MACD crossbull · 1d
Stoch %K / %D94 / 91
ADX (14)36
+DI / −DI31 / 10
RSI divergence—
MACD divergence—
ATR %+3.84%
ADR %4.29%
52w high149.94
52w low51.07
From 52w high+0.00%
Above 52w low+193.60%
New 52w highYes
SqueezeOff
Bollinger width14.00%
%B1.15
Donchian pos95.27%
Donchian high151.08
Donchian low126.97
AVWAP (52w high)149.51
vs AVWAP high+0.29%
AVWAP (52w low)89.49
vs AVWAP low+67.56%
OBV trendUp
Chaikin MF (20)0.12
Today vs 20d2.69×
Avg vol (14d)581.66K
Avg vol (20d)600.44K
Avg $ vol (20d)83.05M
Market cap9.7B
RS 3m (vs SPY)+41.87%
RS 6m (vs SPY)+66.71%
RS line new highNo
Trend template8/8
Technical rank93.4
1 week+13.35%
1 month+14.09%
3 months+50.91%
6 months+77.46%
1 year+194.23%
YTD+71.99%
P/E-74.55
P/B11.53
P/S—
P/FCF173.01
EPS-2.05
Div yield—
ROE-15.47%
ROA-14.70%
Debt/Eq0.01
Current21.71
EV/EBITDA-59.24
Gross margin—
Net margin—
Rev growth—
EPS growth-147.29%
Price target159.18
Target upside6.16%
Analyst ratingBuy
Institutional131.69%
Ent. value9.29B
Revenue213.47M
Net income162.85M
Gross profit—
Free cash flow56.08M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out64.31M
Employees131
ListedThu, Aug 11, 2016
Free float59.71M
Float %93.6%
Short interest8.29M
Days to cover9.5d
Short volume78.3%
Squeeze score88 / 100
Next earnings—
EPS forecast—
Last EPS vs est$2.29 vs $2.11
Last surprise+8.5% beat
Setup gradeA+
Conviction100 / 100
Pattern quality—
Tech rank93.4 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance142.20
Support113.40
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in PTGX
No recent disclosed trades by Congress in PTGX. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in PTGX · 4 buys · 6 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Waddill William D. Director · Common Stock · 2026-06-23 | Sell | 9K | $1.1M | 2026-06-23 | 2026-06-25 |
Waddill William D. Director · Stock Option (right to buy) · 2026-06-23 | Exercise | 9K | — | 2026-06-23 | 2026-06-25 |
Waddill William D. Director · Common Stock · 2026-06-23 | Exercise | 9K | $149K | 2026-06-23 | 2026-06-25 |
Waddill William D. Director · Common Stock · 2026-05-29 | Exercise | 9K | $106K | 2026-05-29 | 2026-06-01 |
Waddill William D. Director · Stock Option (right to buy) · 2026-05-29 | Exercise | 9K | $0 | 2026-05-29 | 2026-06-01 |
Waddill William D. Director · Common Stock · 2026-05-29 | Sell | 9K | $897K | 2026-05-29 | 2026-06-01 |
PATEL DINESH V PH D President and CEO · Stock Option (right to buy) · 2026-05-12 | Exercise | 75K | $0 | 2026-05-12 | 2026-05-14 |
PATEL DINESH V PH D President and CEO · Common Stock · 2026-05-12 | Sell | 75K | $7.5M | 2026-05-12 | 2026-05-14 |
PATEL DINESH V PH D President and CEO · Common Stock · 2026-05-12 | Exercise | 75K | $1.6M | 2026-05-12 | 2026-05-14 |
PATEL DINESH V PH D President and CEO · Common Stock · 2026-05-12 | Exercise | 75K | $1.6M | 2026-05-12 | 2026-05-12 |
SEC filings
EDGAR filings in PTGX · 6 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.